Dallas, Texas (PRWEB) November 07, 2014 One key trend in this market is the reformulation of marketed drugs. Reformulated drugs, usually, have better tolerability and better dosing schedules than the original drugs. This increases the market acceptance of such drugs, driving their market revenue. According to the Global Epilepsy Market 2014-2018 report" (http://www.reportsnreports.com/reports/314564-global-epilepsy-market-2014-2018.html), unmet medical needs are one of the major drivers of the market. Lack of safe, efficacious, and disease-modifying treatment is a major unmet need. Currently, drugs administered for epilepsy are intended to treat seizures. However, they fail to check the progression of the disease. The report recognizes the following companies as the key players in the Global Epilepsy Market: GlaxoSmithKline plc, Pfizer Inc. and UCB SA. Other Prominent Vendors in the market are: Abbvie, Eisai, F. Hoffmann-La Roche, H. Lundbeck and Janssen Pharmaceuticals. Market Driver Market Trend Further, the report states that Generic erosion is one of the major challenges in the market. This, in turn, decreases the market revenue of individual drugs. Order a copy of this report at (Prices start at US $2500 for a single user PDF) http://www.reportsnreports.com/purchase.aspx?name=314564. List of Exhibits Exhibit 1: Market Research Methodology Exhibit 2: Global Epilepsy Market 2013-2018 (US$ million) … Continue reading →

PUBLIC RELEASE DATE: 6-Nov-2014 Contact: Keith Darce darce.keith@scrippshealth.org 858-678-7121 Scripps Health @scrippshealth LA JOLLA, CALIF. -- A research team led by scientists at the Scripps Translational Science Institute (STSI) has used whole genome sequencing to identify a new genetic cause of a severe, rare and complex form of epilepsy that becomes evident in early childhood and can lead to early death. The researchers found a mutation in the KCNB1 gene after mapping the DNA of a 10-year-old girl who suffers from epileptic encephalopathy. The findings were reported in the October edition of the peer-reviewed medical journal Annals of Neurology. The KCNB1 gene encodes the Kv2.1 voltage-gated potassium channel, which regulates the flow of potassium ions through neurons, affecting how the cells communicate with one another. The voltage-gated potassium channel also regulates potassium flow in the kidney, which affects potassium excretion and fluid balance. The link between the KCNB1 mutation and epileptic encephalopathy has opened new treatment options for the young patient, said Robert Bjork, M.D., her physician and a member of the Scripps Memorial Hospital La Jolla staff. Earlier this year, "her prognosis was grim and appeared hopeless when she was experiencing many convulsive seizures, could barely eat or drink, … Continue reading →

NEWS Posted YESTERDAY, 5:24 PM Updated YESTERDAY, 5:24 PM SAN ANTONIO - An alternative type of medical treatment is proving to be successful in helping children with autism. The technique, which combines homeopathy, chiropractic, Chinese and Western medicine, has helped some children so much that theyve been removed from the autism spectrum. Four-year-old Lake Laird is one of the those children. Lake suffers from eczema and severe allergies. On top of that, in January he was diagnosed as mildly autistic. "Our goal is for our child to be healthy and happy," said Lake's mother, Dana Laird. "As a parent, when you see your child struggling you will do anything to help them; any alternative therapy." Lake is being treated with a unique treatment called the Nambudripad allergy elimination technique. "A lot of children with autism, they have a lot of food sensitivities. So if their autism is related to sensitivities and if we reverse the sensitivities, then the child gets better," said Patricia Lew, licensed acupuncturist and NAET practitioner. See the rest here: Alternative medical treatment helps children with autism … Continue reading →

A Madison stem cell company has developed a blood test that could enable earlier diagnosis and treatment of children with autism spectrum disorders, according to research published in a major scientific journal Friday. The findings by Stemina Biomarker Discovery, which collaborated with the MIND Institute at the University of California-Davis, could lead to treatment of children at a younger age that would be individually tailored to a childs condition. What we think were going to revolutionize is not only diagnosing earlier but also being able to distinguish one child with autism from another based on their metabolism, said Stemina chief executive Beth Donley. Autism is a very diverse disorder. Kids have very different behaviors and cognitive abilities. Some are extraordinarily smart but socially awkward. Some are non-verbal. Through early diagnosis, she said, its possible to determine whether relatively simple treatments such as modified diet or dietary supplements would be effective or whether more extensive drug treatment is needed. Not everyone who has autism is the same, and they dont all respond to the same treatment, Donley said. The current average age of diagnosis in the United States is 4.5 years. Blood testing can diagnose children as early as age 2 … Continue reading →

By Chris Johnson for MailOnline Published: 10:29 EST, 7 November 2014 | Updated: 15:33 EST, 7 November 2014 639 shares 313 View comments Actor and comedian Jerry Seinfeld believes he is on the autism spectrum, he revealed in an interview on Thursday night. The 60-year-old star said he finds social engagement difficult and struggles to read meaning from people's facial expressions and body language. Seinfeld - who is married with three children - was speaking on the NBC Nightly News With Brian Williams show. Scroll down for video Revelation: Jerry Seinfeld said he believes he is on the autism spectrum in an interview on the NBC Nightly News With Brian Williams on Thursday night More here: Jerry Seinfeld believes he is on the autism spectrum as he reveals struggles with social engagement … Continue reading →